Increased Fibroblast Growth Factor 21 in Nonalcoholic Fatty Liver Disease

被引:0
|
作者
Dushay, Jody
Chui, Patricia
Gopalakrishnan, Gosala S.
Varelarey, Marta
Crawley, Meghan
Fisher, Ffolliott M.
Badman, Michael K.
Martinez-Chantar, Maria L.
Maratos-Flier, Eleftheria
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A414 / A414
页数:1
相关论文
共 50 条
  • [41] PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE
    Eren, F.
    Kurt, R.
    Ermis, F.
    Atug, O.
    Imeryuz, N.
    Yilmaz, Y.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S537 - S537
  • [42] Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease
    Eren, Fatih
    Kurt, Ramazan
    Ermis, Fatih
    Atug, Ozlen
    Imeryuz, Nese
    Yilmaz, Yusuf
    CLINICAL BIOCHEMISTRY, 2012, 45 (09) : 655 - 658
  • [43] Nonalcoholic fatty liver disease in Asia: A story of growth
    Wong, Vincent Wai-Sun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) : 18 - 23
  • [44] Childhood Growth and Nonalcoholic Fatty Liver Disease in the Adulthood
    Lazo, Mariana
    Brancati, Frederick L.
    Selvin, Elizabeth
    Hernaez, Ruben
    Clark, Jeanne M.
    DIABETES, 2012, 61 : A388 - A388
  • [45] Fibroblast Growth Factor 21: A New Liver Safeguard
    Cariello, Marica
    Moschetta, Antonio
    HEPATOLOGY, 2014, 60 (03) : 792 - 794
  • [46] Fibroblast Growth Factor 21 Signaling: The Liver in Focus
    Mahlapuu, Margit
    Marschall, Hanns-Ulrich
    HEPATOLOGY, 2016, 64 (02) : 333 - 335
  • [47] Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: Association with liver fibrosis
    Colak, Yasar
    Senates, Ebubekir
    Coskunpinar, Ender
    Oltulu, Yasemin Musteri
    Zemheri, Ebru
    Ozturk, Oguzhan
    Doganay, Levent
    Mesci, Banu
    Yilmaz, Yusuf
    Enc, Feruze Yilmaz
    Kiziltas, Safak
    Ulasoglu, Celal
    Tuncer, Ilyas
    DISEASE MARKERS, 2012, 33 (02) : 77 - 83
  • [48] Development of Nonalcoholic Fatty Liver in Superoxide Dismutase-1 Knockout Mice Was Associated with Altered Expression of Hepatic Fibroblast Growth Factor-21
    Chakraborty, Debrup
    Lei, Xin Gen
    FASEB JOURNAL, 2016, 30
  • [49] Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease
    Dichtel, Laura E.
    Cordoba-Chacon, Jose
    Kineman, Rhonda D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (07): : 1812 - 1824
  • [50] Is nonalcoholic fatty liver disease a risk factor for chronic kidney disease?
    Ozturk, Kadir
    Demirci, Hakan
    Kurt, Omer
    Kantarcioglu, Murat
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (05) : 608 - 609